Search for: "WATSON PHARMACEUTICALS "
Results 221 - 240
of 359
Sort by Relevance
|
Sort by Date
15 Mar 2011, 6:29 am
Watson is an early sighting of a highly disruptive force. [read post]
14 Mar 2011, 4:31 am
From a press release, Morristown, NJ, 14 March 2011:Watson Pharmaceuticals, Inc. , today announced that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) does not infringe United States Patent Nos. 6,200,604 or 6,974,590 (the '604 and '590 Patents) and that the '604 and '590 Patents are invalid. [read post]
8 Mar 2011, 7:54 am
Generic versions of Topamax, known generally as topiramate, are sold by Teva Pharmaceuticals, Watson Pharmaceuticals, and Mylan as well as other generic drug companies. [read post]
15 Feb 2011, 5:26 pm
: Ineos Healthcare v OHMI – Teva (Class 46) Androderm (Testosterone) – US: Watson settles with Promote Innovation in Androderm false marking suit (Patent Docs) Asacol (Mesalamine) – US: Roxane sanctioned in Asacol patent dispute with Medeva (Patent Docs) Detrol (Tolterodine) – US: Subsequent ANDA sponsor says Detrol LA patent has gotta go; But would a final court decision trigger 180-day exclusivity? [read post]
15 Feb 2011, 4:57 pm
WorkCover NSW’s General Manager of Work Health and Safety Division John Watson said safety for workers should be the highest priority for employers, particularly in workplaces where heavy machinery is being handled. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
31 Jan 2011, 6:50 pm
Check out these featured jobs courtesy of GoInhouse.com: Counsel – Confidential, Bergen County, NJ Associate General Counsel – eHealthInsurance, Mountain View, CA Attorney – Pacific Northwest National Laboratory, Richland, WA Counsel – Towers Watson, Washington, DC (New York, Philadelphia, Arlingto) Counsel – Towers Watson, New York, NY (Philadelphia, Arlingto) Compliance Counsel – Confidential, New York, NY (Midtown Manhattan) Intellectual… [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
21 Jan 2011, 6:38 am
Senate (see our previous posts here and here) critical of the Agency’s recent characterization of the 12-year reference product exclusivity period provided by the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) as “marketing exclusivity” rather than “data exclusivity,” several generic drug manufacturers (Hospira, Momenta Pharmaceuticals, Hospira, Mylan Labs, Teva Pharmaceuticals, and Watson… [read post]
19 Jan 2011, 3:23 pm
In a study using 2006 Irish Census data, Dorothy Watson and Peter Lunn operationalise some of these ideas. [read post]
19 Jan 2011, 2:44 pm
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
13 Jan 2011, 2:52 pm
., provides for safe disposal of controlled substances, including dangerous pharmaceuticals that can hurt wildlife when they are dumped in the trash or flushed away, and end up in the environment. [read post]
11 Jan 2011, 11:07 pm
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O)… [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
13 Dec 2010, 11:41 am
Watson said while workplace injuries in New South Wales are at their lowest levels in two decades, there is still more work to be done. [read post]
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
10 Dec 2010, 2:31 pm
Watson Laboratories, Inc., C.A. [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
6 Dec 2010, 10:56 am
“Every worker has the right to expect that they will return home safely to their loved ones at the end of their working day,” Watson said. [read post]
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]